Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Hiroya TakeuchiDave S B Hoon

Abstract

Detection of micrometastases in sentinel lymph nodes (SLNs) is important for accurate staging and prognosis in melanoma patients. However, a significant number of patients with histopathology-negative SLNs subsequently develop recurrent disease. We hypothesized that a quantitative realtime reverse transcriptase polymerase chain reaction (qRT) assay using multiple specific mRNA markers could detect occult metastasis in paraffin-embedded (PE) SLNs to upstage and predict disease outcome. qRT was performed on retrospectively collected PE SLNs from 215 clinically node-negative patients who underwent lymphatic mapping and sentinel lymphadenectomy for melanoma and were followed up for at least 8 years. PE SLNs (n = 308) from these patients were sectioned and assessed by qRT for mRNA of four melanoma-associated genes: MART-1 (antigen recognized by T cells-1), MAGE-A3 (melanoma antigen gene-A3 family), GalNAc-T (beta1-->4-N-acetylgalactosaminyl-transferase), and Pax3 (paired-box homeotic gene transcription factor 3). Fifty-three (25%) patients had histopathology-positive SLNs by hemotoxylin and eosin and/or immunohistochemistry. Of the 162 patients with histopathology-negative SLNs, 48 (30%) had nodes that expressed at least one of the ...Continue Reading

References

Apr 1, 1992·Archives of Surgery·D L MortonA J Cochran
Jan 1, 1987·Journal of the National Cancer Institute·T TsuchidaR F Irie
Jan 1, 1987·Journal of the National Cancer Institute·T TsuchidaR F Irie
Aug 15, 1984·International Journal of Cancer. Journal International Du Cancer·A J CochranH R Herschman
Aug 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D S HoonD L Morton
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y KawakamiS A Rosenberg
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J BostickD S Hoon
Nov 4, 1998·JAMA : the Journal of the American Medical Association·S C ShiversD S Reintgen
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G PalmieriG Castello
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J BostickD S Hoon
Sep 15, 2000·CA: a Cancer Journal for Clinicians·D S Rigel, J A Carucci
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G PalmieriUNKNOWN Melanoma Cooperative Group
May 29, 2001·American Journal of Medical Genetics·K L Maschhoff, H S Baldwin
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchJ F Thompson
Feb 7, 2002·The Journal of Biological Chemistry·Anil Kumar KamarajuMichel Revel
Dec 7, 2002·Nature Genetics·Sridhar RamaswamyTodd R Golub
Dec 20, 2002·The New England Journal of Medicine·Marc J van de VijverRené Bernards
Feb 6, 2003·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Aug 13, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine T KuoBret Taback
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Dec 8, 2009·International Journal of Clinical Oncology·Yoichi Moroi
Jun 1, 2005·Journal of the American College of Surgeons·Kelly M McMasters
May 27, 2008·Actas dermo-sifiliográficas·C MangasC Ferrándiz
Jan 22, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Eijun ItakuraAlistair J Cochran
Dec 25, 2008·Nature Clinical Practice. Oncology·Allison R LarsonRhoda M Alani
Jan 7, 2006·Nature Reviews. Cancer·Ewan J D RobsonMichael R Eccles
Feb 24, 2005·Current Opinion in Oncology·Sima Torabian, Mohammed Kashani-Sabet
Feb 28, 2008·Current Opinion in Oncology·Alistair J CochranScott W Binder
Jul 29, 2010·The American Journal of Dermatopathology·Ophelia E DadzieMeera Mahalingam
Jun 24, 2010·Applied Immunohistochemistry & Molecular Morphology : AIMM·Gino R SomersPaul S Thorner
Oct 15, 2011·The American Journal of Surgical Pathology·Eijun ItakuraAlistair J Cochran
Jul 5, 2006·Cancer Research·Takuji MoriDave S B Hoon
Apr 28, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liqiang XiTony E Godfrey
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yasufumi GotoDave S B Hoon
Feb 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Farin F AmersiDave S B Hoon
Nov 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kazuo KoyanagiDave S B Hoon
Nov 13, 2008·Molecular Cancer Therapeutics·Yasufumi GotoDave S B Hoon
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kazuo KoyanagiDave S B Hoon
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sojun HoshimotoDave S B Hoon
Jul 26, 2006·Annals of Surgical Oncology·Simone MocellinCarlo Riccardo Rossi
Jun 29, 2007·Annals of Surgical Oncology·James E GervasoniBlake Cady
Sep 21, 2007·Annals of Surgical Oncology·Randall P ScheriDonald L Morton
Jun 19, 2007·Annals of Surgical Oncology·Donald L MortonCharles M Balch
Nov 24, 2011·Annals of Surgical Oncology·Mark B Faries, Donald L Morton
Feb 12, 2008·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·John F Thompson
Feb 18, 2014·Critical Reviews in Oncology/hematology·Stefan RodicRamy R Saleh
Mar 3, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·F VendittelliE Capoluongo
Sep 2, 2006·The Journal of Investigative Dermatology·Peter D BoasbergSteven J O'Day
Nov 26, 2010·Cancer Treatment Reviews·Andrianos NezosMichael Koutsilieris
Apr 20, 2010·Journal of the American Academy of Dermatology·William G StebbinsArthur J Sober
Mar 10, 2012·The Journal of Investigative Dermatology·Sojun HoshimotoDave S B Hoon
Jul 10, 2009·The Journal of Investigative Dermatology·Yasufumi GotoDave S B Hoon
Apr 25, 2006·Surgical Oncology Clinics of North America·Steve R MartinezDave S B Hoon
Mar 21, 2007·Pigment Cell Research·Sandra MedicMel Ziman
Dec 5, 2008·Experimental Dermatology·Markus Braun-FalcoWolfgang Weyers
Apr 2, 2008·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Rikke Riber-HansenTorben Steiniche

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved